Results 71 to 80 of about 55,376 (183)

Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

Nature Genetics, 2002
H. Meijers-Heijboer, A. V. D. van den Ouweland, J. Klijn, Marijke Wasielewski, Anja de Snoo, R. Oldenburg, A. Hollestelle, Mark Houben, E. Crepin, M. V. van Veghel-Plandsoen, F. Elstrodt, C. V. van Duijn, C. Bartels, C. Meijers, M. Schutte, L. McGuffog, D. Thompson, D. Easton, N. Sodha, S. Seal, R. Barfoot, J. Mangion, J. Chang-Claude, D. Eccles, R. Eeles, D. Evans, R. Houlston, V. Murday, S. Narod, T. Peretz, J. Peto, C. Phelan, H. Zhang, C. Szabo, P. Devilee, D. Goldgar, P. Futreal, K. Nathanson, B. Weber, N. Rahman, M. Stratton   +40 more
semanticscholar   +1 more source

A woman with a pleural mesothelioma and an inherited <i>ATM</i> mutation-a case report. [PDF]

Ann Transl Med
Seca M, Cho BCJ, Tryon A, Narod SA.
europepmc   +1 more source

Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer. [PDF]

Int J Mol Sci, 2023
Zhu JW, Wong F, Szymiczek A, Ene GEV, Zhang S, May T, Narod SA, Kotsopoulos J, Akbari MR.   +8 more
europepmc   +1 more source

Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.

Journal of the American Medical Association (JAMA), 2015
J. Iqbal, O. Ginsburg, P. Rochon, P. Sun, S. Narod   +4 more
semanticscholar   +1 more source

Blood Lead (Pb) Levels as a Possible Marker of Cancer Risk in a Prospective Cohort of Women with Non-Occupational Exposure. [PDF]

Biomedicines
Lubiński K, Lener MR, Marciniak W, Pawłowski J, Sadzikowska J, Kiljańczyk A, Matuszczak M, Baszuk P, Pietrzak S, Derkacz R, Bryśkiewicz M, Cybulski C, Gronwald J, Dębniak T, Huzarski T, Narod SA, Scott RJ, Lubiński J.   +17 more
europepmc   +1 more source

Looking for BRCA1 and BRCA2 mutations in Asian women with breast cancer. [PDF]

Ann Transl Med, 2023
Narod SA.
europepmc   +1 more source

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Narod SA, Dube MP, Klijn J, et al. J Natl Cancer Inst 2002; 94(23): 1773-1779.

Journal of family planning and reproductive health care, 2003
K. Weaver
semanticscholar   +1 more source

Analysis of <i>GEN1</i> as a Breast Cancer Susceptibility Gene in Polish Women. [PDF]

Int J Mol Sci
Gliniewicz K, Wokołorczyk D, Kluźniak W, Stempa K, Huzarski T, Rudnicka H, Jakubowska A, Szwiec M, Jarkiewicz-Tretyn J, Cechowska M, Domagała P, Dębniak T, Lener M, Gronwald J, Lubiński J, Narod SA, Akbari MR, Cybulski C.   +17 more
europepmc   +1 more source

Theory-based behavior change intervention to increase uptake of risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial. [PDF]

Cancer Med, 2023
Metcalfe KA, Pal T, Narod SA, Armel S, Shickh S, Buckley K, Walters ST, Brennenstuhl S, Kinney AY.   +8 more
europepmc   +1 more source

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.

Journal of Clinical Oncology, 2014
A. Finch, J. Lubiński, P. Møller, C. Singer, B. Karlan, L. Senter, B. Rosen, L. Maehle, P. Ghadirian, C. Cybulski, T. Huzarski, A. Eisen, W. Foulkes, C. Kim-sing, P. Ainsworth, N. Tung, H. Lynch, S. Neuhausen, K. Metcalfe, I. Thompson, Joan Murphy, P. Sun, S. Narod   +22 more
semanticscholar   +1 more source